LAX.SH
ACUTAAS CHEMICALS LIMITED·PHARMACEUTICALS 66.37·Pharmaceuticals & Biotechnology Companies
Price
3,215.3
+1.99%52W Range
Market Cap
₹26,324.02 Cr
Traded: ₹99.26 Cr (0.38%) 0.0x
Free Float: ₹5,704.42 Cr (1.74% of FF traded)
Volume · 60D trend
3.09 L 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
RS Score
Create a free account to unlock your edge
Scanners, market pulse, FII/DII data, and TradingView charts — free forever
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
MTF Exposure Trend
60 sessions · funded amount, % of FF, daily delta
LAX.SH
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| Return | -- | -- | +78.0% | +178.0% | -- | Accelerating |
| Profit | -- | +46.0% | +62.0% | -- | +104.0% | Accelerating |
| Sales | -- | +32.0% | +30.0% | -- | +41.0% | Stable |
| ROE | +20.0% | +18.0% | +18.0% | -- | -- | Stable |
Quarterly Results
Mar 2023
Dec 2022
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 330 | 433 | 393 | 306 | 207 | 308 | 275 | 247 | 177 | 225 | 166 | 172 | 154 | 186 | 152 |
| Expenses | 217 | 249 | 243 | 211 | 156 | 224 | 206 | 198 | 147 | 182 | 140 | 148 | 120 | 146 | 122 |
| Operating Profit | 113 | 184 | 151 | 95 | 51 | 85 | 69 | 49 | 30 | 43 | 27 | 25 | 34 | 41 | 31 |
| Other Income | 2 | 11 | 5 | 10 | 16 | 6 | 2 | 8 | 1 | 1 | 3 | -30 | 1 | 0 | 3 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 4 | 2 | 3 | 1 | 1 | 1 | 1 |
| Depreciation | 10 | 10 | 10 | 8 | 8 | 7 | 6 | 7 | 6 | 5 | 4 | 4 | 4 | 3 | 3 |
| Profit Before Tax | 104 | 184 | 145 | 96 | 58 | 83 | 63 | 50 | 20 | 37 | 24 | -10 | 31 | 37 | 30 |
| Tax % | 28.0% | 27.0% | 27.0% | 25.0% | 24.0% | 24.0% | 28.0% | 25.0% | 26.0% | 31.0% | 25.0% | 71.0% | 28.0% | 26.0% | 25.0% |
| Net Profit | 75 | 134 | 106 | 72 | 44 | 63 | 45 | 38 | 15 | 26 | 18 | -17 | 22 | 27 | 22 |
| Exceptional Items | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | -32 | 0 | 0 | 0 |
| EPS (Rs) | 9.1 | 16.1 | 13.2 | 8.8 | 5.4 | 7.6 | 5.5 | 4.6 | 1.7 | 3.4 | 2.3 | -2.5 | 2.7 | 3.7 | 3.1 |
| Sales Growth (YoY) | 59.4% | 40.6% | 42.9% | 23.9% | 16.9% | 36.9% | 65.7% | 43.6% | 14.9% | 21.0% | 9.2% | -- | -- | -- | -- |
| Sales Growth (QoQ) | -23.8% | 10.2% | 28.4% | 47.8% | -32.8% | 12.0% | 11.3% | 39.5% | -21.3% | 35.5% | -3.5% | 11.7% | -17.2% | 22.4% | -- |
| OP Growth (YoY) | 121.6% | 116.5% | 118.8% | 93.9% | 70.0% | 97.7% | 155.6% | 96.0% | -11.8% | 4.9% | -12.9% | -- | -- | -- | -- |
| OP Growth (QoQ) | -38.6% | 21.9% | 58.9% | 86.3% | -40.0% | 23.2% | 40.8% | 63.3% | -30.2% | 59.3% | 8.0% | -26.5% | -17.1% | 32.3% | -- |
| Profit Growth (YoY) | -- | 111.0% | 140.0% | 94.0% | 217.0% | 146.0% | 168.0% | 540.0% | -29.0% | -7.0% | -25.0% | -69.0% | 33.0% | 28.0% | 14.0% |
| EPS Growth (YoY) | 67.7% | 110.9% | 140.3% | 93.4% | 216.4% | 123.8% | 141.8% | 278.8% | -36.9% | -8.6% | -25.8% | -- | -- | -- | -- |
| EPS Growth (QoQ) | -43.6% | 22.0% | 49.5% | 63.0% | -29.1% | 39.0% | 20.4% | 166.7% | -49.9% | 50.2% | 189.0% | -194.1% | -27.4% | 21.9% | -- |
| OP Margin | 34.2% | 42.5% | 38.4% | 31.1% | 24.6% | 27.6% | 25.1% | 19.8% | 16.9% | 19.1% | 16.3% | 14.5% | 22.1% | 22.0% | 20.4% |
| Net Margin | 22.7% | 30.9% | 27.0% | 23.5% | 21.3% | 20.4% | 16.4% | 15.4% | 8.5% | 11.6% | 10.8% | -9.9% | 14.3% | 14.5% | 14.5% |
| Material Cost % | -- | 38.0% | 43.0% | 44.2% | 46.8% | 52.7% | 53.8% | 56.6% | 57.9% | 60.0% | 57.1% | 59.0% | 52.1% | 56.4% | 54.0% |
| Employee Cost % | -- | 7.7% | 7.6% | 9.6% | 12.1% | 7.5% | 7.9% | 8.0% | 10.8% | 7.6% | 9.7% | 9.2% | 9.2% | 6.2% | 8.4% |
| P/S | 18.01 | 21.15 | 16.88 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | 68.16 | 79.50 | 71.40 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 15.92 | 17.12 | 14.49 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Credit Ratings
3Concalls
21Feb 2026
28 Feb 2026Oct 2025
31 Oct 2025Aug 2025
31 Aug 2025May 2025
31 May 2025Feb 2025
28 Feb 2025Nov 2024
30 Nov 2024Aug 2024
31 Aug 2024May 2024
31 May 2024May 2024
31 May 2024Feb 2024
29 Feb 2024Nov 2023
30 Nov 2023Aug 2023
31 Aug 2023May 2023
31 May 2023Feb 2023
28 Feb 2023Feb 2023
28 Feb 2023Nov 2022
30 Nov 2022Aug 2022
31 Aug 2022Aug 2022
31 Aug 2022May 2022
31 May 2022Feb 2022
28 Feb 2022Oct 2021
31 Oct 2021Held by ETFs
22 ETFs hold acutaas · sorted by weight
Held by Mutual Funds
81 schemes hold acutaas · sorted by weight